IRIS
FERRO, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.905
EU - Europa 3.207
AS - Asia 731
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
SA - Sud America 2
Totale 7.851
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.886
IE - Irlanda 1.008
SE - Svezia 854
CN - Cina 554
UA - Ucraina 380
IT - Italia 330
DE - Germania 236
FI - Finlandia 170
GB - Regno Unito 131
VN - Vietnam 119
IN - India 43
BE - Belgio 37
RU - Federazione Russa 22
CA - Canada 18
FR - Francia 15
AT - Austria 11
A2 - ???statistics.table.value.countryCode.A2??? 3
IR - Iran 3
JP - Giappone 3
NL - Olanda 3
SG - Singapore 3
CH - Svizzera 2
CL - Cile 2
MA - Marocco 2
RO - Romania 2
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
KR - Corea 1
LV - Lettonia 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TR - Turchia 1
Totale 7.851
Salva come PNG Salva come JPEG
Città #
Dublin 1.006
Jacksonville 779
Chandler 726
Nyköping 577
Beijing 278
Ashburn 217
Princeton 179
Dearborn 170
Cambridge 167
Medford 160
Des Moines 131
Ann Arbor 127
Dong Ket 116
Messina 113
Boardman 106
Lancaster 60
Wilmington 48
Woodbridge 48
Jinan 41
San Mateo 40
Pune 37
Brussels 35
Shenyang 34
Catania 29
Nanjing 28
Haikou 20
Hebei 20
Hangzhou 15
Ningbo 15
Seattle 15
New York 14
Taizhou 13
Fuzhou 11
Ottawa 11
Vienna 11
Francofonte 10
Zhengzhou 10
Guangzhou 9
Houston 9
Norwalk 9
Tianjin 9
Washington 9
Lappeenranta 8
Taiyuan 8
Nanchang 7
Nicotera 7
Jiaxing 6
Saint Petersburg 6
Auburn Hills 5
Changsha 5
Clearwater 5
Falls Church 5
Leawood 5
Brooklyn 4
Chicago 4
Hefei 4
Kunming 4
Milan 4
Montréal 4
Rome 4
West Jordan 4
Ardabil 3
Augusta 3
Borghetto Santo Spirito 3
Brugherio 3
Como 3
Helsinki 3
Ho Chi Minh City 3
London 3
Mcallen 3
Mumbai 3
Phoenix 3
Siena 3
Alghero 2
Carugate 2
Fiorenzuola D'arda 2
Furci Siculo 2
Guspini 2
Hanover 2
Kharkov 2
Lanzhou 2
Larne 2
Leonforte 2
Los Angeles 2
Monmouth Junction 2
Monselice 2
Munich 2
Novokuznetsk 2
Pagani 2
Parma 2
Rende 2
Saint Louis 2
Shanghai 2
Tappahannock 2
Torino 2
Trecastagni 2
Turin 2
Acton 1
Agadir 1
Albuquerque 1
Totale 5.648
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 189
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 127
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 93
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 90
AMPA receptor antagonists: Synthesis and pharmacological evaluation 88
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 83
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 77
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 76
Graphene Quantum Dots Based Systems As HIV Inhibitors 76
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 75
Sintesi e SAR di nuovi inibitori dell'acetilcolinesterasi come potenziali agenti anti-Alzheimer 73
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 72
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 72
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 67
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 66
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 65
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 64
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 63
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 62
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 61
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 61
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 61
NOVEL N1-ARYL-2- ARYLTHIOACETAMIDOBENZIMIDAZOLES WERE EFFECTIVE AGAINST HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION IN VITRO 61
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 60
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 59
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 59
Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75 59
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 58
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 58
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 58
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 57
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors. 57
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 57
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 57
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 57
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors 56
Antiretroviral strategy using multi-target agents 56
HIV-1 integrase strand-transfer inhibitors: design and synthetic strategies in the process of a lead optimization 56
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 56
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 55
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 55
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 55
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 55
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 55
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 54
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 54
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 53
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 53
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 52
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 52
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 52
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 52
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 52
Discovery of potent HIV-1 integrase strand transfer inhibitors: design and synthetic strategies 52
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 52
Combined ligand-based and target-based approach to design NR2B/NMDA receptor antagonists 51
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 51
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 51
Pharmacophore-based design of HIV-1 integrase inhibitors 50
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 50
Progettazione e sintesi di antagonisti non competitivi del recettore NR2B/NMDA 50
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 50
Pharmacophore based design of HIV-1 integrase inhibitors 49
Rational design, synthesis and SAR of 1,3-dihydro-benzimidazolone analogues as new anti-HIV agents 49
HIV-1 integrase inhibitors as anti-AIDS agents: Structure-Activity Relationships (SAR) of new diketo acids and analogs 49
INTEGRASE STRAND TRANSFER INHIBITORS (INSTIs): SYNTHESIS AND ANTIVIRAL EFFETCS OF CHLORO-FLUORO SUBSTITUTIONS 49
Insight into the INSTIs binding mode: molecular modeling investigation and SAR studies 49
Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of Benzenesulfonamides 49
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 48
HIV-1 integrase strand transfer inhibitors (INSTIs): design, synthesis and biological activity 48
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 48
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 48
Progettazione, Sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 48
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 48
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 48
ISOQUINOLINE-SULFONAMIDES AS A CLASS OF POTENT AND SELECTIVE CARBONIC ANHYDRASE INHIBITORS 48
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 47
Progettazione e Sintesi di Nuovi Inibitori dell'Integrasi dell'HIV-1 47
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 47
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 47
New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of action 47
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 47
Analysis of Italian regulations on pathways of care for patients in a vegetative or minimally conscious state 47
New Indole derivatives as NMDA/NR2B rrceptor antagonists: design, synthesis and pharmacological properties 46
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 46
HIV-1-IN Strand-Transfer Inhibitors: phenyl ring exploration and synthesis of 1H-benzylindole derivative through fluorine substitutions 46
Computational studies and synthetic approaches for the identification of new protein-protein interaction inhibitors (PPI) 46
Microwave assisted organic synthesis (MAOS) of small molecules as potential HIV-1 integrase inhibitors. 46
Synthesis and biological characterization of novel potent arylsulfonamides as human carbonic anhydrase inhibitors (hCAIs) targeting central nervous system 46
Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. 46
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 45
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 45
New potent and selective carbonic anhydrase inhibitors: synthesis, biological evaluation and X-ray studies 44
Synthesis and biological profile of new 1,2,3,4-tetrahydroisoquinolines as selective carbonic anhydrase inhibitors 44
Synthesis and Biological Characterization of 3-Substituted-1H-indoles as Ligands of GluN2B-Containing N-Methyl-d-aspartate Receptors 44
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 44
Molecular Modeling, synthesis and SAR of anti-HIV agents 43
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase 43
Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 43
Synthesis of new potential HIV-1 integrase inhibitors 42
Totale 5.714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.351
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 11 17 8
2019/20201.296 217 94 5 83 5 171 169 125 20 190 209 8
2020/20211.179 130 6 198 52 54 123 17 142 38 142 85 192
2021/20221.060 10 161 25 48 38 11 81 39 28 11 258 350
2022/20232.901 242 254 143 218 212 297 54 148 1.232 8 74 19
2023/2024551 57 102 50 134 56 124 7 16 1 4 0 0
Totale 8.029